JP7148680B2 - 血中ニコチン濃度減少用組成物、及びその製造法 - Google Patents
血中ニコチン濃度減少用組成物、及びその製造法 Download PDFInfo
- Publication number
- JP7148680B2 JP7148680B2 JP2021116629A JP2021116629A JP7148680B2 JP 7148680 B2 JP7148680 B2 JP 7148680B2 JP 2021116629 A JP2021116629 A JP 2021116629A JP 2021116629 A JP2021116629 A JP 2021116629A JP 7148680 B2 JP7148680 B2 JP 7148680B2
- Authority
- JP
- Japan
- Prior art keywords
- ions
- composition
- extract
- hydrogen
- selenium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims description 61
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 title claims description 46
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 title claims description 46
- 229960002715 nicotine Drugs 0.000 title claims description 46
- 239000008280 blood Substances 0.000 title claims description 30
- 210000004369 blood Anatomy 0.000 title claims description 30
- 238000004519 manufacturing process Methods 0.000 title claims description 29
- 230000001603 reducing effect Effects 0.000 title claims description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 75
- 239000000284 extract Substances 0.000 claims description 61
- -1 silver ions Chemical class 0.000 claims description 58
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 47
- 239000001257 hydrogen Substances 0.000 claims description 43
- 229910052739 hydrogen Inorganic materials 0.000 claims description 43
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 42
- 239000011707 mineral Substances 0.000 claims description 42
- 150000002500 ions Chemical class 0.000 claims description 39
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 32
- 229910052732 germanium Inorganic materials 0.000 claims description 29
- 229910052711 selenium Inorganic materials 0.000 claims description 29
- 239000011669 selenium Substances 0.000 claims description 29
- 229910052709 silver Inorganic materials 0.000 claims description 27
- 239000004332 silver Substances 0.000 claims description 27
- 244000010000 Hovenia dulcis Species 0.000 claims description 26
- 235000008584 Hovenia dulcis Nutrition 0.000 claims description 26
- 239000007864 aqueous solution Substances 0.000 claims description 26
- 241000209219 Hordeum Species 0.000 claims description 25
- 235000007340 Hordeum vulgare Nutrition 0.000 claims description 25
- 235000013361 beverage Nutrition 0.000 claims description 20
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 claims description 18
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 claims description 18
- 229910001431 copper ion Inorganic materials 0.000 claims description 18
- 239000000843 powder Substances 0.000 claims description 18
- 229960004543 anhydrous citric acid Drugs 0.000 claims description 16
- 230000033116 oxidation-reduction process Effects 0.000 claims description 16
- 229930091371 Fructose Natural products 0.000 claims description 15
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 15
- 239000005715 Fructose Substances 0.000 claims description 15
- 239000007788 liquid Substances 0.000 claims description 15
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 claims description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 10
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 10
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 9
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 9
- 239000011701 zinc Substances 0.000 claims description 9
- 229910052725 zinc Inorganic materials 0.000 claims description 9
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 8
- 229910052802 copper Inorganic materials 0.000 claims description 8
- 239000010949 copper Substances 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 7
- 230000009467 reduction Effects 0.000 claims description 6
- 235000010755 mineral Nutrition 0.000 description 37
- 230000000694 effects Effects 0.000 description 18
- 239000001301 oxygen Substances 0.000 description 15
- 229910052760 oxygen Inorganic materials 0.000 description 15
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 14
- 238000000034 method Methods 0.000 description 14
- 230000000052 comparative effect Effects 0.000 description 13
- 238000005516 engineering process Methods 0.000 description 12
- 238000002474 experimental method Methods 0.000 description 12
- 239000011435 rock Substances 0.000 description 10
- 235000019441 ethanol Nutrition 0.000 description 9
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
- 241000196324 Embryophyta Species 0.000 description 8
- 150000001768 cations Chemical class 0.000 description 7
- 235000013305 food Nutrition 0.000 description 7
- 230000003908 liver function Effects 0.000 description 7
- 238000002156 mixing Methods 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- UIKROCXWUNQSPJ-VIFPVBQESA-N (-)-cotinine Chemical compound C1CC(=O)N(C)[C@@H]1C1=CC=CN=C1 UIKROCXWUNQSPJ-VIFPVBQESA-N 0.000 description 6
- UIKROCXWUNQSPJ-UHFFFAOYSA-N Cotinine Natural products C1CC(=O)N(C)C1C1=CC=CN=C1 UIKROCXWUNQSPJ-UHFFFAOYSA-N 0.000 description 6
- 229950006073 cotinine Drugs 0.000 description 6
- 238000005868 electrolysis reaction Methods 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 208000006454 hepatitis Diseases 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 239000008213 purified water Substances 0.000 description 6
- 229910052751 metal Inorganic materials 0.000 description 5
- 239000002184 metal Substances 0.000 description 5
- 230000000391 smoking effect Effects 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 210000002700 urine Anatomy 0.000 description 5
- 206010008909 Chronic Hepatitis Diseases 0.000 description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 4
- 244000269722 Thea sinensis Species 0.000 description 4
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 4
- 241000209140 Triticum Species 0.000 description 4
- 235000021307 Triticum Nutrition 0.000 description 4
- 229930003268 Vitamin C Natural products 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 238000001784 detoxification Methods 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 231100000334 hepatotoxic Toxicity 0.000 description 4
- 230000003082 hepatotoxic effect Effects 0.000 description 4
- 231100000304 hepatotoxicity Toxicity 0.000 description 4
- 239000010936 titanium Substances 0.000 description 4
- 229910052719 titanium Inorganic materials 0.000 description 4
- 235000019154 vitamin C Nutrition 0.000 description 4
- 239000011718 vitamin C Substances 0.000 description 4
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 3
- 101000856500 Bacillus subtilis subsp. natto Glutathione hydrolase proenzyme Proteins 0.000 description 3
- 241000555678 Citrus unshiu Species 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 206010019851 Hepatotoxicity Diseases 0.000 description 3
- 206010067125 Liver injury Diseases 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- 229910045601 alloy Inorganic materials 0.000 description 3
- 239000000956 alloy Substances 0.000 description 3
- 150000001450 anions Chemical class 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- 235000019504 cigarettes Nutrition 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 230000005611 electricity Effects 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 208000019622 heart disease Diseases 0.000 description 3
- 230000007686 hepatotoxicity Effects 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000001606 7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one Substances 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 206010001605 Alcohol poisoning Diseases 0.000 description 2
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241001093501 Rutaceae Species 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 108090000340 Transaminases Proteins 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 231100000354 acute hepatitis Toxicity 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 2
- HNYOPLTXPVRDBG-UHFFFAOYSA-N barbituric acid Chemical compound O=C1CC(=O)NC(=O)N1 HNYOPLTXPVRDBG-UHFFFAOYSA-N 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- 235000009569 green tea Nutrition 0.000 description 2
- 231100000234 hepatic damage Toxicity 0.000 description 2
- 229940025878 hesperidin Drugs 0.000 description 2
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 2
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000008818 liver damage Effects 0.000 description 2
- 208000019423 liver disease Diseases 0.000 description 2
- 239000002075 main ingredient Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- 229930019673 naringin Natural products 0.000 description 2
- DFPMSGMNTNDNHN-ZPHOTFPESA-N naringin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=CC(O)=CC=2)O[C@H](CO)[C@@H](O)[C@@H]1O DFPMSGMNTNDNHN-ZPHOTFPESA-N 0.000 description 2
- 229940052490 naringin Drugs 0.000 description 2
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 230000001932 seasonal effect Effects 0.000 description 2
- 238000009331 sowing Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 231100000041 toxicology testing Toxicity 0.000 description 2
- 102000014898 transaminase activity proteins Human genes 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- FTVWIRXFELQLPI-ZDUSSCGKSA-N (S)-naringenin Chemical compound C1=CC(O)=CC=C1[C@H]1OC2=CC(O)=CC(O)=C2C(=O)C1 FTVWIRXFELQLPI-ZDUSSCGKSA-N 0.000 description 1
- HGUFODBRKLSHSI-UHFFFAOYSA-N 2,3,7,8-tetrachloro-dibenzo-p-dioxin Chemical compound O1C2=CC(Cl)=C(Cl)C=C2OC2=C1C=C(Cl)C(Cl)=C2 HGUFODBRKLSHSI-UHFFFAOYSA-N 0.000 description 1
- OQKYVRDRDIXQMK-KETMJRJWSA-N 2-(3,4-dihydroxyphenyl)-5-hydroxy-6-[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-7-[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1O)[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=CC2=C1C(=O)C=C(C=1C=C(O)C(O)=CC=1)O2 OQKYVRDRDIXQMK-KETMJRJWSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- HGUVPEBGCAVWID-KETMJRJWSA-N 7-O-(beta-D-glucosyl)isovitexin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1O)[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=CC2=C1C(=O)C=C(C=1C=CC(O)=CC=1)O2 HGUVPEBGCAVWID-KETMJRJWSA-N 0.000 description 1
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 1
- 108010082126 Alanine transaminase Proteins 0.000 description 1
- 240000007087 Apium graveolens Species 0.000 description 1
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 1
- 235000010591 Appio Nutrition 0.000 description 1
- 108700016171 Aspartate ammonia-lyases Proteins 0.000 description 1
- 206010003645 Atopy Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 241001672694 Citrus reticulata Species 0.000 description 1
- 229910000881 Cu alloy Inorganic materials 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 206010013654 Drug abuse Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 206010019728 Hepatitis alcoholic Diseases 0.000 description 1
- 206010019837 Hepatocellular injury Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- NXXWLQYGFANBST-UHFFFAOYSA-N Isoorientin-7-O-glucosid Natural products OCC1OC(Oc2cc3OC(=CC(=O)c3cc2C4OC(CO)C(O)C(O)C4O)c5ccc(O)c(O)c5)C(O)C(O)C1O NXXWLQYGFANBST-UHFFFAOYSA-N 0.000 description 1
- 208000001145 Metabolic Syndrome Diseases 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 208000029578 Muscle disease Diseases 0.000 description 1
- 208000029549 Muscle injury Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010057852 Nicotine dependence Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 206010062519 Poor quality sleep Diseases 0.000 description 1
- 241000219100 Rhamnaceae Species 0.000 description 1
- JMFSHKGXVSAJFY-UHFFFAOYSA-N Saponaretin Natural products OCC(O)C1OC(Oc2c(O)cc(O)c3C(=O)C=C(Oc23)c4ccc(O)cc4)C(O)C1O JMFSHKGXVSAJFY-UHFFFAOYSA-N 0.000 description 1
- 244000261559 Smilax china Species 0.000 description 1
- 235000000485 Smilax china Nutrition 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- 208000025569 Tobacco Use disease Diseases 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- MOZJVOCOKZLBQB-UHFFFAOYSA-N Vitexin Natural products OCC1OC(Oc2c(O)c(O)cc3C(=O)C=C(Oc23)c4ccc(O)cc4)C(O)C(O)C1O MOZJVOCOKZLBQB-UHFFFAOYSA-N 0.000 description 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 208000002353 alcoholic hepatitis Diseases 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 229940069780 barley extract Drugs 0.000 description 1
- 238000006065 biodegradation reaction Methods 0.000 description 1
- 235000020279 black tea Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036765 blood level Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 1
- 239000001527 calcium lactate Substances 0.000 description 1
- 235000011086 calcium lactate Nutrition 0.000 description 1
- 229960002401 calcium lactate Drugs 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- WPUMTJGUQUYPIV-JIZZDEOASA-L disodium (S)-malate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](O)CC([O-])=O WPUMTJGUQUYPIV-JIZZDEOASA-L 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 235000019990 fruit wine Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 235000020510 functional beverage Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 239000008169 grapeseed oil Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 229940094952 green tea extract Drugs 0.000 description 1
- 235000020688 green tea extract Nutrition 0.000 description 1
- 239000000383 hazardous chemical Substances 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 201000010235 heart cancer Diseases 0.000 description 1
- 208000024348 heart neoplasm Diseases 0.000 description 1
- AIONOLUJZLIMTK-UHFFFAOYSA-N hesperetin Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(O)=CC(O)=C2C(=O)C1 AIONOLUJZLIMTK-UHFFFAOYSA-N 0.000 description 1
- 235000010209 hesperetin Nutrition 0.000 description 1
- AIONOLUJZLIMTK-AWEZNQCLSA-N hesperetin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O)=CC(O)=C2C(=O)C1 AIONOLUJZLIMTK-AWEZNQCLSA-N 0.000 description 1
- 229960001587 hesperetin Drugs 0.000 description 1
- FTODBIPDTXRIGS-UHFFFAOYSA-N homoeriodictyol Natural products C1=C(O)C(OC)=CC(C2OC3=CC(O)=CC(O)=C3C(=O)C2)=C1 FTODBIPDTXRIGS-UHFFFAOYSA-N 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical compound [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 231100000405 induce cancer Toxicity 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- MYXNWGACZJSMBT-VJXVFPJBSA-N isovitexin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=C(OC(=CC2=O)C=3C=CC(O)=CC=3)C2=C1O MYXNWGACZJSMBT-VJXVFPJBSA-N 0.000 description 1
- OYJCWTROZCNWAA-UHFFFAOYSA-N isovitexin Natural products OCC1OC(C(O)C(O)C1O)c2c(O)cc3CC(=CC(=O)c3c2O)c4ccc(O)cc4 OYJCWTROZCNWAA-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 230000005976 liver dysfunction Effects 0.000 description 1
- 238000007449 liver function test Methods 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 230000007056 liver toxicity Effects 0.000 description 1
- SLJVIWCEWPUMET-UHFFFAOYSA-N lutonarin Natural products OCC1OC(Oc2cc3OC(=CC(=O)c3c(O)c2OC4OC(CO)C(O)C(O)C4O)c5ccc(O)c(O)c5)C(O)C(O)C1O SLJVIWCEWPUMET-UHFFFAOYSA-N 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 230000004898 mitochondrial function Effects 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- WGEYAGZBLYNDFV-UHFFFAOYSA-N naringenin Natural products C1(=O)C2=C(O)C=C(O)C=C2OC(C1)C1=CC=C(CC1)O WGEYAGZBLYNDFV-UHFFFAOYSA-N 0.000 description 1
- 235000007625 naringenin Nutrition 0.000 description 1
- 229940117954 naringenin Drugs 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 239000008239 natural water Substances 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 229960001109 policosanol Drugs 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- HGUVPEBGCAVWID-UHFFFAOYSA-N saponarin Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)C2C(C(O)C(O)C(CO)O2)O)=CC2=C1C(=O)C=C(C=1C=CC(O)=CC=1)O2 HGUVPEBGCAVWID-UHFFFAOYSA-N 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- 125000003748 selenium group Chemical group *[Se]* 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- BSWGGJHLVUUXTL-UHFFFAOYSA-N silver zinc Chemical compound [Zn].[Ag] BSWGGJHLVUUXTL-UHFFFAOYSA-N 0.000 description 1
- 235000019265 sodium DL-malate Nutrition 0.000 description 1
- HELHAJAZNSDZJO-OLXYHTOASA-L sodium L-tartrate Chemical compound [Na+].[Na+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O HELHAJAZNSDZJO-OLXYHTOASA-L 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 229940001593 sodium carbonate Drugs 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 239000001394 sodium malate Substances 0.000 description 1
- 229940001584 sodium metabisulfite Drugs 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- 239000001433 sodium tartrate Substances 0.000 description 1
- 229960002167 sodium tartrate Drugs 0.000 description 1
- 235000011004 sodium tartrates Nutrition 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 238000012453 sprague-dawley rat model Methods 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- YWYZEGXAUVWDED-UHFFFAOYSA-N triammonium citrate Chemical compound [NH4+].[NH4+].[NH4+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O YWYZEGXAUVWDED-UHFFFAOYSA-N 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 239000002349 well water Substances 0.000 description 1
- 235000020681 well water Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
- A23L2/04—Extraction of juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/46—Treatment of water, waste water, or sewage by electrochemical methods
- C02F1/461—Treatment of water, waste water, or sewage by electrochemical methods by electrolysis
- C02F1/467—Treatment of water, waste water, or sewage by electrochemical methods by electrolysis by electrochemical disinfection; by electrooxydation or by electroreduction
- C02F1/4676—Treatment of water, waste water, or sewage by electrochemical methods by electrolysis by electrochemical disinfection; by electrooxydation or by electroreduction by electroreduction
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/14—Extraction
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Hydrology & Water Resources (AREA)
- Inorganic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Environmental & Geological Engineering (AREA)
- Water Supply & Treatment (AREA)
- Organic Chemistry (AREA)
- Electrochemistry (AREA)
- Mycology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Non-Alcoholic Beverages (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Description
この段階は、銅、亜鉛、銀、セレニウム、ゲルマニウムを陽極にして水を電気分解して、銅イオン、亜鉛イオン、銀イオン、セレニウムイオン、ゲルマニウムイオンを含有したミネラルイオン水溶液を製造する過程である。
この段階は、前記段階(a)で製造したミネラルイオン水溶液を原水として、水素ガスを加圧噴射する段階(b);を含む過程により水素還元水を製造するか、或いは、前記段階(a)で製造したミネラルイオン水溶液を原水として、電気分解する段階(b’);を含む過程により水素還元水を製造する過程である。
銅(1/6重量比)、亜鉛(3/6重量比)、銀(2/6重量比)を配合した合金として単一の基礎電極板1kgを作り、セレニウム含有岩石500g、ゲルマニウム含有岩石500gをチタニウムコートされた金網中に閉じ込め、上記の合金板に通電するように取付けることにより、総(トータルで)2kgの電極板を製造した。
前記製造例1で製造したミネラルイオン水溶液の100Lを原水とし、密閉タンク中に原水と5気圧の水素ガスを同時に加圧噴射して、-300mVの酸化還元電位を有する100Lの水素還元水を製造した。
播種して約12日後に収穫した麦の若芽(若い麦の根部分を除く全ての部分)を乾燥させた後に粉末化して麦の若芽粉末を製造した。麦の若芽粉末100kgに抽出溶媒である発酵酒精150Lを加え、室温で24時間撹拌して抽出した後、アドバンテックのNo.2の濾紙で濾過した。その後、濾液を凍結乾燥させて麦の若芽抽出粉末10kgを製造した。
ケンポナシ葉、木部(枝、樹皮も含む。)を乾燥させた後、1対1の重量比で混合して粉末化することによってケンポナシ粉末を製造した。ケンポナシ粉末100kgに、抽出溶媒である発酵酒精150Lを加えて、室温で24時間撹拌して抽出した後、アドバンテックのNo.2濾紙で濾過した。その後、濾液を凍結乾燥させてケンポナシ抽出粉末10kgを製造した。
キッピ(ウンシュウミカン(Citrus unshiu Markovich)の皮)を乾燥した後に粉末化してキッピ粉末を製造した。キッピ粉末100kgに抽出溶媒である発酵酒精150Lを加えて室温で24時間撹拌して抽出した後、アドバンテック番号2濾紙で濾過した。その後、濾液を凍結乾燥させてキッピ抽出粉末10kgを製造した。
上記で製造したミネラルイオンを含有した水素還元水96重量%、上記で製造した麦の若芽抽出粉末1重量%、上記で製造したケンポナシ抽出粉末1重量%、上記で製造したキッピ抽出粉末1重量%、液状果糖0.5重量%、及び無水クエン酸0.5重量%を混合して本発明のニコチン分解用飲料組成物100Lを製造した。
精製水96重量%、麦の若芽抽出粉末3重量%、液状果糖0.5重量%、及び無水クエン酸0.5重量%を混合して比較例1の飲料組成物100Lを製造した。
精製水96重量%、ケンポナシ抽出粉末3重量%、液状果糖0.5重量%、及び無水クエン酸0.5重量%を混合して比較例2の飲料組成物100Lを製造した。
精製水96重量%、キッピ抽出粉末3重量%、液状果糖0.5重量%、及び無水クエン酸0.5重量%を混合して比較例3の飲料組成物100Lを製造した。
本実験では、本発明組成物の血中ニコチン濃度減少の効果を確認しようとした。前記実施例1で製造された本発明組成物のニコチン分解の効果を検証するために、市販のタバコを2年以上吸っている20~30代の健康な男子20人を対象にして実験を行った。
本実験例では、本発明組成物の肝毒性解毒効果を確認しようとした。実験動物は、5週齢のネズミ(sprague dawley(SD) rat)60匹を利用した。実験動物として使用するSDラット(BioGenomics Inc.)は一般に毒性検査に広く使用される種であり、毒性テストに要求される条件を満たす。各群当たり15匹にし、総4群(実施例1、比較例1、比較例2、比較例3)に分けて実験した。
本実験例では、本発明組成物の肝機能改善の実験を行った。実施例1で製造された飲料組成物を、35~50歳の男性のうちの肝機能異常患者50人に1日200mLずつ3回、30日間服用させた後、摂取前後の肝機能関連指数であるGPT、GOT、γ-GTPを測定した。
Claims (8)
- 銅イオン、亜鉛イオン、銀イオン、セレニウムイオン、及びゲルマニウムイオンを含有した水素還元水、麦の若芽抽出物、ケンポナシ抽出物、及びキッピ抽出物を含むことを特徴とする血中ニコチン濃度減少用組成物。
- 前記血中ニコチン濃度減少用組成物は、
液状果糖及び無水クエン酸をさらに含むことを特徴とする、請求項1に記載の血中ニコチン濃度減少用組成物。 - 前記血中ニコチン濃度減少用組成物は、
ミネラルイオンを含有した水素還元水94~98重量%、麦の若芽抽出物0.5~1.5重量%、ケンポナシ抽出物0.5~1.5重量%、キッピ抽出物0.5~1.5重量%、液状果糖0.25~0.75重量%、及び無水クエン酸0.25~0.75重量%で組成されることを特徴とする、請求項2に記載の血中ニコチン濃度減少用組成物。 - 前記組成物は、
飲料であることを特徴とする、請求項1に記載の血中ニコチン濃度減少用組成物。 - 前記麦の若芽抽出物、ケンポナシ抽出物、キッピ抽出物のそれぞれは、
酒精を抽出溶媒として用いて抽出した抽出物であり、粉末であることを特徴とする、請求項1に記載の血中ニコチン濃度減少用組成物。 - 前記銅イオン、亜鉛イオン、銀イオン、セレニウムイオン、及びゲルマニウムイオンを含有した水素還元水は、
-200mV~-500mVの酸化還元電位を有することを特徴とする、請求項1に記載の血中ニコチン濃度減少用組成物。 - 前記-200mV~-500mVの酸化還元電位を有する銅イオン、亜鉛イオン、銀イオン、セレニウムイオン、及びゲルマニウムイオンを含有した水素還元水は、
銅、亜鉛、銀、セレニウム、ゲルマニウムを陽極にして水を電気分解して、銅イオン、亜鉛イオン、銀イオン、セレニウムイオン、ゲルマニウムイオンを含有したミネラルイオン水溶液を製造する段階(a);
前記段階(a)で製造したミネラルイオン水溶液を原水とし、水素ガスを加圧噴射する段階(b);を含む過程から得られたものであり、-200mV~-500mVの酸化還元電位を有することを特徴とする、請求項6に記載の血中ニコチン濃度減少用組成物の製造方法。 - 前記-200mV~-500mVの酸化還元電位を有する銅イオン、亜鉛イオン、銀イオン、セレニウムイオン、及びゲルマニウムイオンを含有した水素還元水は、
銅、亜鉛、銀、セレニウム、ゲルマニウムを陽極にして水を電気分解して、銅イオン、亜鉛イオン、銀イオン、セレニウムイオン、及びゲルマニウムイオンを含有したミネラルイオン水溶液を製造する段階(a);
前記段階(a)で製造したミネラルイオン水溶液を原水とし、電気分解する段階(b’);を含む過程から得られたものであり、-200mV~-500mVの酸化還元電位を有することを特徴とする、請求項6に記載の血中ニコチン濃度減少用組成物の製造方法。
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20200086527 | 2020-07-14 | ||
KR10-2020-0086527 | 2020-07-14 | ||
KR1020200153643A KR102261122B1 (ko) | 2020-07-14 | 2020-11-17 | 혈중 니코틴 농도 감소용 조성물 |
KR10-2020-0153643 | 2020-11-17 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2022025032A JP2022025032A (ja) | 2022-02-09 |
JP7148680B2 true JP7148680B2 (ja) | 2022-10-05 |
Family
ID=76374497
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021116629A Active JP7148680B2 (ja) | 2020-07-14 | 2021-07-14 | 血中ニコチン濃度減少用組成物、及びその製造法 |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP7148680B2 (ja) |
KR (1) | KR102261122B1 (ja) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013510139A (ja) | 2009-11-11 | 2013-03-21 | ジョン ヒュン ナム | 喫煙毒性解毒用組成物 |
KR101544570B1 (ko) | 2014-12-17 | 2015-08-13 | 주식회사 블루텍 | 숙취해소용 및 간기능 개선용 음료 조성물 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100446641B1 (ko) | 1999-07-16 | 2004-09-04 | 주식회사 리젠 바이오텍 | 니코틴 분해음료 및 제재 |
JP4131327B2 (ja) | 2003-09-22 | 2008-08-13 | 日産自動車株式会社 | 車両用運転操作補助装置および車両用運転操作補助装置を備えた車両 |
KR100494223B1 (ko) | 2005-01-26 | 2005-06-16 | (주)세포활성연구소 | 니코틴 및 타르 해독을 위한 복합 천연 조성물 |
KR101037210B1 (ko) | 2008-03-20 | 2011-05-26 | 구일건설(주) | 교각을 이용하여 교량을 인상하는 장치 |
KR20110065875A (ko) * | 2009-12-10 | 2011-06-16 | 정대준 | 미네랄을 함유한 농수축산용 농축 액상 및 그 제조방법 |
KR101222455B1 (ko) | 2012-10-15 | 2013-01-15 | (주)이노게이트 | 수소환원수 제조장치 |
KR101483592B1 (ko) | 2012-11-20 | 2015-01-16 | 대한민국 | 새싹보리 추출물을 유효성분으로 포함하는 혈중 알코올 농도 감소 또는 간 기능 개선용 조성물 |
KR20170103390A (ko) * | 2016-03-04 | 2017-09-13 | 주식회사 블루텍 | 미네랄이온활성수를 포함하는 무독성 방부 조성물 |
KR101900304B1 (ko) | 2018-05-31 | 2018-09-19 | 김성은 | 녹차 추출물 및 흑차 추출물을 함유하는 니코틴 해독용 조성물 및 이의 제조방법 |
-
2020
- 2020-11-17 KR KR1020200153643A patent/KR102261122B1/ko active IP Right Grant
-
2021
- 2021-07-14 JP JP2021116629A patent/JP7148680B2/ja active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013510139A (ja) | 2009-11-11 | 2013-03-21 | ジョン ヒュン ナム | 喫煙毒性解毒用組成物 |
KR101544570B1 (ko) | 2014-12-17 | 2015-08-13 | 주식회사 블루텍 | 숙취해소용 및 간기능 개선용 음료 조성물 |
Also Published As
Publication number | Publication date |
---|---|
KR102261122B1 (ko) | 2021-06-07 |
JP2022025032A (ja) | 2022-02-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11464821B2 (en) | Composition for reducing cancer cachexia or weight loss caused by anticancer drug therapy or radiation therapy comprising ginseng extract having increased ginsenoside Rg3 and Rh2 | |
KR101301094B1 (ko) | 숙취해소 또는 간 기능 개선용 조성물 | |
US20060134232A1 (en) | Herbal supplement for cognitive related impairment due to estrogen loss | |
KR102062716B1 (ko) | 숙성노니원액이 함유된 숙취해소용 음료조성물 및 그의 제조방법 | |
KR101544570B1 (ko) | 숙취해소용 및 간기능 개선용 음료 조성물 | |
KR20150111724A (ko) | 소취능 및 항산화능을 가지는 반려동물용 음료 조성물 | |
KR102105111B1 (ko) | 생리활성성분이 강화된 에너지 음료 조성물 및 그 제조방법 | |
KR101103576B1 (ko) | 죽순과 죽엽을 이용한 숙취 해소용 조성물 및 간 기능 개선용 조성물 | |
KR101525478B1 (ko) | 숙취해소용 식품 조성물 | |
JP7148680B2 (ja) | 血中ニコチン濃度減少用組成物、及びその製造法 | |
KR102127411B1 (ko) | 복합 천연 추출물을 함유하는 간기능 보호 및 숙취해소용 조성물 | |
KR102433586B1 (ko) | 숙취 해소 및 간 기능 개선용 식품 조성물 | |
KR20190101063A (ko) | 천연물질 추출물을 함유하는 기관지 질환 예방 및 개선을 위한 조성물 및 그 제조방법 | |
KR102322276B1 (ko) | 비만 예방 및 부종 개선용 음료 조성물 | |
KR20040030360A (ko) | 반도 심층수 또는 그 농축분말을 함유하는 간 질환의 치료및 예방용 조성물 | |
KR100684436B1 (ko) | 항산화, 지질과산화 억제에 따른 항노화, 항염증 및 거담 활성을 갖는 단풍마 및 가시오가피 혼합추출물을 함유하는 조성물 | |
CA2398747C (en) | Herbal supplement containing galanthamine for treating symptoms of estrogen-deficiency | |
KR20130060436A (ko) | 가공 인삼 추출물을 함유한 간보호 효과를 나타내는 식품첨가물 | |
KR102039623B1 (ko) | 간세포 보호용 엉겅퀴 과립 조성물 및 이의 제조방법 | |
CN108721176B (zh) | 一种漱口水及其制备方法 | |
KR20120016688A (ko) | 숙취 예방 또는 해소용 조성물 | |
KR20100003068A (ko) | 기능성 소금 및 이의 제조방법 | |
KR101489923B1 (ko) | 천연 생약추출물을 포함하는 숙취해소용 음료 조성물 및 이의 제조방법 | |
KR20230107967A (ko) | 숙취 해소 및 간 보호용 액상 조성물 | |
KR101480728B1 (ko) | 흑마늘 추출물을 포함하는 유자차 및 그 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210803 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20210803 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20220906 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20220922 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7148680 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |